Muharrem Yunce, MD
Anatomic Pathology & Clinical Pathology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Yunce’s office at (650) 723-4000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A155917 · Current
Licensed to practise in California · since 2018 · expires 2027-10-31 · Dicle University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
- American Board of Pathology - Blood Banking/Transfusion Medicine
Medicaid work
$5,230 in 2021
Medicaid paid $5,230 for 76 billed services this clinician did in 2021, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 76 | $5,230 |
| 2021 | 76 | 1 | 14 | $5,230 |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 47 Part D prescriptions in 2020. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2021 | 27 | None | None | None | $2,570 |
| 2020 | 47 | 16 | 0% (0) | None | $1,508 |
| 2018 | 222 | 64 | None | None | $16,509 |
| 2017 | 385 | 98 | 0% (0) | None | $30,535 |
| 2016 | 173 | 58 | None | 27% | $15,232 |
| 2015 | 35 | 21 | None | None | $3,594 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2018: 4 drugs
| Amlodipine Besylate | 30 | $230 | $8 |
| Atorvastatin | 15 | $227 | $15 |
| Lisinopril | 13 | $74 | $6 |
| Metformin | 12 | $47 | $4 |
2017: 9 drugs
| Lantus Solostar | 15 | $7,848 | $523 |
| Atorvastatin | 33 | $320 | $10 |
| Metoprolol | 11 | $262 | $24 |
| Amlodipine Besylate | 30 | $169 | $6 |
| Metformin | 20 | $108 | $5 |
| Lisinopril | 23 | $104 | $5 |
| Metoprolol | 16 | $92 | $6 |
| Ranitidine | 12 | $85 | $7 |
| Hydrochlorothiazide | 12 | $47 | $4 |
Money from drug and device companies
$141 in 2023
| 2023 | 1 | 1 | None | $141 |
| 2022 | 1 | 1 | None | $65 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Genzyme | Cablivi | $141 | 1 payment
|
See the published payment
| Genzyme | Meals · 2023-04-27 | Cablivi | $141 |
See earlier years (2022)
2022: $65
| Terumo BCT | Spectra Optia | $65 | 1 payment
|
Professional record
- NPI
- 1841685047
- Licence
- CA A155917California A155917: Current · expires 2027-10-31
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207ZP0102X (207ZP0102X); Internal medicine (207R00000X); Federal specialty code 207ZB0001X (207ZB0001X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2015-04-03
- NPI last updated
- 2025-05-06
- NPI record certified
- 2025-05-06
This is when the NPI record was last certified, not a medical board exam.